InflaRx Announces November Investor Events
InflaRx announced its November events calendar, including conference appearances at the Guggenheim Healthcare Innovation Conference and Jefferies Global Healthcare Conference. The company will report Q3 2026 results on November 3 before market open via a Form 6-K, the same day as its previously announced virtual Capital Markets Day focused on izicopan in ANCA-associated vasculitis.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.